What is 3,4-Methylenedioxymethamphetamine (bk-MDMA)?

Category: Others

false

See also: MDMA-assisted Psychotherapy

MDMA (3,4-methylenedioxymethamphetamine, also called ecstasy) is a synthetic compound with structural and pharmacologic similarities to both amphetamines and mescaline. First developed in 1914 as an appetite suppressant, MDMA found use as a psychotherapeutic agent during the 1970s.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Bulimia nervosa 1 0
Depressed mood 1 0
Diagnostic assessment 1 0
Epilepsy 1 1
Self hatred or loathing 1 0

  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations
Severe 0
Moderate 0
Mild 1
None 0

Commonly reported side effects and conditions associated with 3,4-Methylenedioxymethamphetamine (bk-MDMA)

Side effect Patients
Insomnia 1

Why patients stopped taking 3,4-Methylenedioxymethamphetamine (bk-MDMA)

Multiple reasons could be selected

Reason Patients
Other 2
Did not seem to work 1
Personal research 1
See all 2 patients who've stopped using 3,4-Methylenedioxymethamphetamine (bk-MDMA)

Duration

Stopped using 3,4-Methylenedioxymethamphetamine (bk-MDMA)

Duration Patients
Less than 1 month 1
1 - 6 months 1
2 - 5 years 1
Adherence
Adherence Evaluations
Always 1
Usually 0
Sometimes 0
Never taken as prescribed 0
Burden
Burden Evaluations
Very hard to take 0
Somewhat hard to take 0
A little hard to take 1
Not at all hard to take 0
Cost per month
Cost per month Evaluations
$200+ 1
$100-199 0
$50-99 0
$25-49 0
< $25 0
Not specified 0
Last updated:

1 patient evaluation for 3,4-Methylenedioxymethamphetamine (bk-MDMA)

Nov 6, 2010 (Started Aug 28, 2010)

  • Effectiveness
    Major (for epilepsy)
  • Side effects
    Mild (insomnia)
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 600 mg Daily
Advice & Tips: The only reason I stopped this treatment was due to availability issues and the fact it is still a schedule 1 research drug for this sort of illness.
Cost: $200+ monthly
Side effects: insomnia

  • 0 helpful marks
Last updated:
Showing 1 of 1 patient evaluation for 3,4-Methylenedioxymethamphetamine (bk-MDMA)